Yu Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Ren has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Akihisa Hidaka
Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan
4 shared publications - Alicja Wolk
Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet , Stockholm
4 shared publications - Amit D. Joshi
Department of Preventive Medicine, University of Southern Cali-fornia, Keck School of Medicine, Los Angeles, California
4 shared publications - Andre E. Kim
Department of Population and Public Health Sciences and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
4 shared publications - Andrea Gsur
Center for Cancer Research, Medical University of Vienna, Vienna, Austria
4 shared publications - Andrew T. Chan
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
4 shared publications
Latest Publications
- Open Access
- 28 July 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Computational Methods for Analysing X-ray-guided Coronary Angiography: From Key Frame Selection to Vessel Segmentation, Stenosis Detection and Classification
Coronary artery disease (CAD) is a leading cause of mortality globally, highlighting the need for accurate diagnostic tools. X-ray-guided coronary angiography is the foundation for assessing CAD, involving three key tasks: key frame selection, vessel segmentation and stenosis detection. This review summarises conventional and advanced artificial intelligence (AI) methods applied to these tasks. AI’s integration is vital for enhancing efficiency and reproducibility, allowing real-time analysis and reducing manual labour. However, challenges remain, including the need for large, annotated datasets and difficulties in implementing AI systems in clinical trials. We discuss these challenges and the limitations of current AI approaches, exploring future directions for AI-driven solutions. Ultimately, we provide insights into AI’s potential to improve the precision and efficiency of coronary angiography analysis and CAD diagnosis, contributing to better clinical outcomes and advancing cardiovascular medicine.
- 28 July 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Open AccessComputational Methods for Analysing X-ray-guided Coronary Angiography: From Key Frame Selection to Vessel Segmentation, Stenosis Detection and Classification
Coronary artery disease (CAD) is a leading cause of mortality globally, highlighting the need for accurate diagnostic tools. X-ray-guided coronary angiography is the foundation for assessing CAD, involving three key tasks: key frame selection, vessel segmentation and stenosis detection. This review summarises conventional and advanced artificial intelligence (AI) methods applied to these tasks. AI’s integration is vital for enhancing efficiency and reproducibility, allowing real-time analysis and reducing manual labour. However, challenges remain, including the need for large, annotated datasets and difficulties in implementing AI systems in clinical trials. We discuss these challenges and the limitations of current AI approaches, exploring future directions for AI-driven solutions. Ultimately, we provide insights into AI’s potential to improve the precision and efficiency of coronary angiography analysis and CAD diagnosis, contributing to better clinical outcomes and advancing cardiovascular medicine.
- Open Access
- 30 May 2023
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (15) , 2572-2583
A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment interactions (G × E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G × E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G × E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G × E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer. Significance: This gene-environment interaction analysis revealed a genetic locus in FMN1/GREM1 that interacts with body mass index in colorectal cancer risk, suggesting potential implications for precision prevention strategies.
- 30 May 2023
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (15) , 2572-2583
Open AccessA Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment interactions (G × E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G × E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G × E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G × E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer. Significance: This gene-environment interaction analysis revealed a genetic locus in FMN1/GREM1 that interacts with body mass index in colorectal cancer risk, suggesting potential implications for precision prevention strategies.
- Open Access
- 16 November 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (21) , 3926
Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia
Abstract 3926
- 16 November 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (21) , 3926
Open AccessVariation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia
Abstract 3926